EHT-1864

N/A

Report date: 2024/12/04 16:49:15
NME

Base Information

Drug NameEHT-1864
Drug Alias NameEHT-1864EHT-0101EHT-0206EHT-101EHT-206
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-secretase modulatorsRas-related C3 botulinum toxin substrate 1 inhibitors
TargetsGamma-secretaseRas-related C3 botulinum toxin substrate 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesExonhit Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesExonhit Therapeutics Sa
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A